RT @parkerici: NEW RESEARCH: CRISPR-edited T-cells appear to be safe in cancer patients in this first-in-human U.S. clinical trial. From @PennCancer, @Parkerici @TmunityTherap #cancerfearsPICI #silosshattered #ASH19 https://t.co/hMO04rNH6g https://t.co/7COXkkqm7U